An injectable dual-functional biomimetic system based on carboxymethyl chitin sulfate and hyaluronic acid for viscosupplementation and sustained triamcinolone acetonide release in osteoarthritis therapy | Synapse
March 3, 2026
An injectable dual-functional biomimetic system based on carboxymethyl chitin sulfate and hyaluronic acid for viscosupplementation and sustained triamcinolone acetonide release in osteoarthritis therapy
Key Points
Viscosupplementation may enhance joint lubrication and pain relief in osteoarthritis patients, leading to improved mobility.
The injectable system showcases a sustained release of triamcinolone acetonide, significantly affecting treatment outcomes.
Analysis using a dual-functional biomimetic system highlights its potential for use in osteoarthritis therapies.
This approach may enable new treatment strategies for osteoarthritis management, addressing unmet medical needs.